Introduction: Immune-mediated inflammatory diseases (IMIDs) are chronic autoimmune conditions that share common pathophysiologic mechanisms. The optimal management of patients with IMIDs remains challenging because the coexistence of different conditions requires the intervention of several specialists. The aim of this study was to develop a series of statements defining overarching principles that guide the implementation of a multidisciplinary approach for the management of spondyloarthritis (SpA)-related IMIDs including SpA, psoriasis, psoriatic arthritis, Crohnâs disease, ulcerative colitis and uveitis. Methods: A Delphi consensus-based approach was used to identify a core set of statements. The process included development of initial questions by a steering committee, an exhaustive search of the literature using complementary approaches to identify potential statements and two Delphi voting rounds for finalization of the statements. Results: Consensus was achieved on the related nature of IMIDs, the existence of a high prevalence of multiple IMIDs in a single patient and the fact that a multidisciplinary approach can result in a more extensive evaluation and comprehensive approach to treatment. The goals of a multidisciplinary team should be to increase diagnosis of concomitant IMIDs, improve the decision-making process, and increase patient satisfaction and adherence. Early referral and diagnosis, early recognition of concomitant IMIDs and optimizing treatment to improve patient quality of life are some of the advantages of using multidisciplinary teams. To be effective, a multidisciplinary team should be equipped with the appropriate tools for diagnosis and follow-up, and at a minimum the multidisciplinary team should include a dermatologist, gastroenterologist and rheumatologist; providing psychologic support via a psychologist and involving an ophthalmologist, general practitioners and nurses in multidisciplinary care is also important. Conclusion: The present Delphi consensus identified a set of overarching principles that may be useful for implementation of a multidisciplinary approach for the management of SpA-related IMIDs. Funding: Aristea and Hippocrates.
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease / F. Rizzello, I. Olivieri, A. Armuzzi, F. Ayala, V. Bettoli, L. Bianchi, L. Cimino, A. Costanzo, A. Cristaudo, S. D’Angelo, M. Daperno, A.C. Fostini, M. Galeazzi, M. Gilio, P. Gionchetti, P. Gisondi, E. Lubrano, A. Marchesoni, A. Offidani, A. Orlando, D. Pugliese, C. Salvarani, R. Scarpa, M. Vecchi, G. Girolomoni. - In: ADVANCES IN THERAPY. - ISSN 0741-238X. - 35:4(2018 Apr), pp. 545-562.
|Titolo:||Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease|
|Parole Chiave:||Crohn's disease; Immune-mediated inflammatory disease; Multidisciplinary; Psoriasis; Psoriatic arthritis; Spondyloarthritis; Ulcerative colitis; Uveitis; Pharmacology (medical)|
|Settore Scientifico Disciplinare:||Settore MED/12 - Gastroenterologia|
|Data di pubblicazione:||apr-2018|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1007/s12325-018-0672-6|
|Appare nelle tipologie:||01 - Articolo su periodico|